The liver's crucial role extends beyond nutrient management; it neutralizes and eliminates numerous harmful substances. This multifaceted functionality has motivated research into liver cell composition and organization under various conditions, including pregnancy—a subject not yet fully explored.
With mice increasingly used in liver research, their resemblance to human liver structure and function underpins many studies. Given mice's growing importance in liver research, establishing a baseline for their liver's normal cellular composition is essential. This foundation will support future investigations into liver function and pathology (Baratta et al., 2009; Naugler et al., 2015).
This study utilized mice to examine cellular and tissue changes in the liver through various histological techniques (H&E, PAS). The findings reveal that the mouse liver shares fundamental structural similarities with livers of other mammals.
Anatomically, the liver is located in the right upper quadrant of the abdomen, presenting as a reddish-brown, wedge-shaped organ with four lobes of varying sizes and shapes. This observation aligns with previous research, highlighting the liver as the largest gland and a significant organ in the body, characterized by its wedge shape and divided into right and left lobes based on external morphology (Mitra & Metcalf, 2012).
The study also explored the impact of pregnancy on maternal body weight and its subsequent effects on the liver. Statistical analysis indicated significant changes in body weight during pregnancy, correlating with increases in liver weight in the pregnant group. These findings are consistent with earlier studies (Milona et al., 2010), which reported a normal weight increase in the liver of pregnant females, attributed to changes in maternal mass and the heightened metabolic demands of the fetoplacental unit.
In a study by done by Grimbert et al. (Grimbert et al., 1993) a marked increase body weight was established statistically with a parallel increase in liver weight and this was explained by fact that pregnancy tend to slightly decrease of amount of mitochondrial protein recovery from the liver showed a marked amount increased (51± 2g) in pregnant than the control which was (27±1g). These studies have a recorded in morphological frequent appearance of double or triple nuclei in pregnancy than in those seen in non-pregnant group.
The liver's cellular organization and its lobular structure are defined by the arrangement of hepatocytes around the central vein, supported by portal areas containing the hepatic triad. These lobules, hexagonal in shape, feature a central vein with radially arranged hepatocytes and intervening liver sinusoids, lined by endothelial and Kupffer cells (Nagarajan, 2019).
The liver's cellularity encompasses both parenchymal (primarily hepatocytes) and non-parenchymal cells (including Kupffer, stellate, and lymphocytes), distinguishable through histological and microscopic techniques (Bowman & Russell, 2006).
Pregnancy induces enhanced hepatic metabolism to meet the increased energy demand and detoxify fetal metabolites. Hepatocytes, often enlarged and multinucleated, show a capacity for increased metabolic activity, contributing to liver enlargement during pregnancy (Milona et al., 2010). This gestational hepatomegaly, alongside metabolic changes affecting enzyme activities, glycolysis, and gluconeogenesis, remains not fully understood. Complications like acute fatty liver and gestational diabetes indicate significant metabolic shifts, with systemic glucose production rising by 16% to support the fetus (Bancroft et al., 2013).
Liver endothelial cells, crucial for organ function, feature fenestrations forming sieve plates, facilitating the movement of small molecules, highlighting the liver's specialized vascular architecture (Pavelka & Roth, 2015).
The maintenance of normal glucose tolerance is facilitated by lactogenic activity, which involves the augmentation of pancreatic islet mass by β-cell hypertrophy and hyperplasia. This process also leads to an enhancement in insulin synthesis and glucose-stimulated insulin secretion, while simultaneously reducing the glucose-stimulation threshold. The endocrine pancreas undergoes modification during gestation in response to two primary stimuli, namely human placental lactogen and prolactin, which are known as lactogens. Ramos-Roman's work examines the impact of lactogens on maintaining glucose balance during pregnancy. It suggests a method via which the hormonal regulation of breastfeeding, primarily by prolactin, may influence the biology of adipocytes, glucose and lipid metabolism, and protect postpartum women from developing type 2 diabetes (Ramos-Roman, 2011)
The present study has observed liver enlargement on the 12th day of pregnancy, indicating that lactogens originating from the placenta may initiate this process. This is because during this time, there is significant development of the placenta, leading to the release of lactogens from the placenta. Additionally, there is a significant increase in maternal hepatic growth hormone and prolactin receptor expression during pregnancy (Cramer et al., 1992). Furthermore, the correlation between liver size and foetal number provides evidence that foetal or placental signals have a role in gestational hepatomegaly. Gaining insight into the signals that trigger liver growth, hepatocyte hypertrophy, and cell-cycle arrest at S/G2 in mice models during pregnancy might provide valuable information for developing safer methods to enhance liver function in women at times of heightened metabolic requirements.
Actually, rodents experience gestational hepatomegaly as a means to accommodate the heightened metabolic requirements placed on the mother liver during the course of pregnancy. The processes and signals behind pregnancy-induced liver expansion remain unknown, despite its significance as a physiological function. In this study, we demonstrate that liver growth in pregnant women occurs before the increase in maternal body weight. This growth is directly related to the number of foetuses and is caused by the enlargement of liver cells, which is connected with the development of the cell cycle, polyploidy, and changes in the expression of cell-cycle regulators such as p53, Cyclin-D1, and p27. Due to the elevated levels of circulating reproductive hormones and bile acids in pregnant women, these substances have the potential to stimulate liver development in rats, making them potential candidates for the signalling pathway responsible for gestational liver enlargement in rodents. The administration of reproductive hormones at pregnancy levels did not provide a significant effect on liver development. However, it was shown that mouse pregnancy was correlated with elevated levels of serum bile acids. The need of the bile acid sensor Fxr for the successful recuperation after partial hepatectomy has been established. In this study, we provide evidence that mice lacking Fxr−/− experience gestational liver expansion via the process of adaptive hepatocyte hyperplasia. This study represents the first discovery of a specific element necessary for the proper functioning of gestational hepatomegaly. Additionally, it suggests that Fxr plays a role in a physiologically normal process that regulates the cell cycle of hepatocytes. According to Milona et al. (Milona et al., 2010) who conclude that understanding pregnancy-induced hepatocyte hypertrophy in mice could suggest mechanisms for safely increasing functional liver capacity in women during increased metabolic demand.
The result of present study consistent with Al-Gayyim and Al-Habib (Al-Gayyim & Al-Habib, 2020) who found maternal liver growth during pregnancy is driven by hepatocyte hyperplasia and hypertrophy. Several waves of hepatocyte proliferation, manifested by increases in the numbers of Ki67-positive hepatocytes and mitotic figures and in maternal hepatic DNA content, were evident as pregnancy progresses. The most prominent waves of hepatocyte proliferation took place on gestation days 8, 13, and 15. Hepatocyte hypertrophy was concomitant with maternal liver mass expansion, especially during the second half of pregnancy. It is noteworthy that, by examining non-pregnant and gestation day 18 livers.
In addition, Gielchinsky et al. (2010) conducted a study that provided evidence for the regeneration of the elderly maternal liver by hepatocyte hypertrophy after partial hepatectomy during pregnancy (Gielchinsky et al., 2010). The results suggest that pregnancy has a significant impact on the recovery of the maternal liver after a substantial loss of mass. Significantly, more recent studies have emphasised the involvement of placental hormones, including prolactin and placental lactogens, in facilitating the hormonal response of the maternal pancreas to pregnancy (Kim et al., 2010).
Whether these hormones take part in regulating maternal liver growth during pregnancy is under investigation.
During pregnancy, there are physiological adaptations that occur in the maternal compartment. This study aimed to investigate the impact of pregnancy on the maternal liver in CD-1 mice. Significant alterations were seen in the dimensions of the maternal liver over the course of pregnancy. The weight of the livers increased twofold from the nonpregnant condition to the 18th day of pregnancy. The hepatomegaly seen during pregnancy was a natural occurrence characterised by liver expansion, as shown by an increase in DNA content and the identification of hepatocyte hyperplasia and hypertrophy. Hepatic growth started after implantation and reached its highest point after parturition. An investigation was conducted to examine the expression and/or activity of crucial genes that are responsible for regulating liver regeneration, which is a process of liver expansion that compensates for the loss of liver mass (Dai et al., 2011).